Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Comet Therapeutics is a developer of therapies designed to treat orphan neurological disorders.
Twentyeight-Seven Therapeutics is a developer of microRNAs designed to target regulatory proteins.
EnobraQ is a Toulouse-based biotechnology company.
Delinia was founded to discover and develop novel therapeutics for the treatment of autoimmune and inflammatory diseases.
Sofinnova Partners has invested in 148 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sofinnova Partners's top investment sectors include Biotechnology, Health Care, Therapeutics, Wellness, Developer Platform. The firm invests across 9 different industry categories.
Among tracked funding rounds, Delinia received $35.0M in a Series A round. Sofinnova Partners's total known invested capital is $6.3B.
Sofinnova Partners's average investment size is $48.1M across its portfolio of 148 companies.